Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-8-1
pubmed:abstractText
Transplantation of bone marrow from unrelated donors is limited by a lack of HLA-matched donors and the risk of graft-versus-host disease (GVHD). Placental blood from sibling donors can reconstitute hematopoiesis. We report preliminary results of transplantation using partially HLA-mismatched placental blood from unrelated donors.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0028-4793
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
335
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
157-66
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8657213-Adolescent, pubmed-meshheading:8657213-Adult, pubmed-meshheading:8657213-Blood Banks, pubmed-meshheading:8657213-Blood Donors, pubmed-meshheading:8657213-Child, pubmed-meshheading:8657213-Child, Preschool, pubmed-meshheading:8657213-Disease-Free Survival, pubmed-meshheading:8657213-Female, pubmed-meshheading:8657213-Fetal Blood, pubmed-meshheading:8657213-Graft vs Host Disease, pubmed-meshheading:8657213-HLA Antigens, pubmed-meshheading:8657213-Hematologic Diseases, pubmed-meshheading:8657213-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:8657213-Histocompatibility Testing, pubmed-meshheading:8657213-Humans, pubmed-meshheading:8657213-Infant, pubmed-meshheading:8657213-Infant, Newborn, pubmed-meshheading:8657213-Male, pubmed-meshheading:8657213-Placenta, pubmed-meshheading:8657213-Survival Rate
pubmed:year
1996
pubmed:articleTitle
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
pubmed:affiliation
Pediatric Bone Marrow Transplant Program, Duke University Medical Center, Durham, NC 27710, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase I